# High Dose Omega 3 in People at Risk for Dementia

> **NCT03926351** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Akershus** · enrollment: 40 (estimated)

## Conditions studied

- Dementia
- Inflammation
- Mild Cognitive Impairment
- Cognitive Decline
- SCD
- Cognitive Dysfunction
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurocognitive Disorders
- Mental Disorder
- Cognition Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 capsules
- **DIETARY_SUPPLEMENT:** Olive oil

## Key facts

- **NCT ID:** NCT03926351
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2019-10
- **Final completion:** 2020-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03926351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03926351, "High Dose Omega 3 in People at Risk for Dementia". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT03926351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*